Key result
Intravascular lithotripsy yields 100% procedural success in balloon-resistant calcified left main lesions.
Why the study?
Calcification with undilatable lesions predicts poor outcomes after left main PCI, and the safety and efficacy of shockwave intravascular lithotripsy (S-IVL) in this setting needed evaluation.
Does shockwave intravascular lithotripsy (S-IVL) improve angiographic success in patients with highly calcified left main coronary artery disease resistant to standard plaque modification?
Observational (n=16)
Yes
Does shockwave intravascular lithotripsy (S-IVL) improve angiographic success in patients with highly calcified left main coronary artery disease resistant to standard plaque modification?
S-IVL is a highly effective bail-out strategy for achieving angiographic success in heavily calcified, undilatable left main lesions, though short-term ischemic risks remain.
Answers are grounded in this paper and cite their sources.
May support S-IVL feasibility in calcified LM PCI; hypothesis-generating and requires larger prospective trials before adoption.
INTRODUCTION: Left main (LM) disease is associated with a large myocardial ischemic territory. Calcification with co-existing undilatable lesions is a predictor of poor clinical outcomes following LM percutaneous coronary interventions (PCI). AIM: To evaluate the safety and efficiency of shockwave intravascular lithotripsy (S-IVL) in highly calcified LM diseases. MATERIAL AND METHODS: The study population consisted of sixteen patients qualified for PCI - mainly males (81.3%) with coronary artery disease (CAD) treated with left main S-IVL PCI due to unsuccessful attempts of plaque modification with a non-compliant (NC) balloon catheter, or rotational devices. Clinical success was defined as effective stent delivery and deployment (with less than < 20% in-stent residual stenosis) with preserved coronary flow TIMI-3 (Thrombolysis in Myocardial Infarction) at the end of the procedure. RESULTS: The most frequent indication for PCI was acute coronary syndrome (ACS) (62.5%). In these high-risk (average Syntax score 24) patients, clinical success of PCI was achieved in 100% of cases. In the short-term observation, we recorded two major adverse cardiac and cerebrovascular events (MACCE) including one fatal, acute stent thrombosis. CONCLUSIONS: Our data suggest that the use of S-IVL is safe and effective as a bail-out strategy to manage LM lesions resistant to high-pressure NC balloon inflation. Despite encouraging initial results, future large studies with long-term observation are required to evaluate the safety and efficacy of S-IVL in LM stenosis.
No takes yet. Share an insight, caveat, or question.
Rola et al. (2021) conducted an observational in Calcified unprotected left main coronary artery disease (n=16). Shockwave intravascular lithotripsy (S-IVL) was evaluated on Clinical success (effective stent delivery and deployment with <20% in-stent residual stenosis and preserved TIMI-3 flow). Shockwave intravascular lithotripsy achieved a 100% clinical success rate for stent delivery and deployment in patients with highly calcified left main coronary lesions resistant to standard balloon inflation.
Synapse has enriched 10 related papers. Consider them for comparative context: